DNA persistence after treatment of Lyme borreliosis (Q42251831)

19 October 2017

title

DNA persistence after treatment of Lyme borreliosis (English)

1 reference

19 October 2017

0 references

D Pícha

1

1 reference

19 October 2017

L Moravcová

2

1 reference

19 October 2017

D Vaňousová

3

1 reference

19 October 2017

J Hercogová

4

1 reference

19 October 2017

Z Blechová

5

1 reference

19 October 2017

publication date

9 August 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

59

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

115-125

1 reference

Course of Borrelia burgdorferi DNA shedding in urine after treatment

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Lyme disease: Part II. Management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Importance of sample preparation for molecular diagnosis of lyme borreliosis from urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Molecular methods for ehrlichiosis and Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

A Critical Appraisal of “Chronic Lyme Disease”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Persistence of Borrelia burgdorferi following antibiotic treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Chronic Lyme disease: the controversies and the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Nucleic Acid Amplification Based Diagnostic of Lyme (Neuro-)borreliosis - Lost in the Jungle of Methods, Targets, and Assays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

PCR in lyme neuroborreliosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Microbiological and serological diagnosis of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Implications of gender in chronic Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12223-013-0272-4

Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis

21 January 2018

1 reference

12 December 2020

PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period

1 reference

12 December 2020

Lyme disease: disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro

1 reference

12 December 2020

Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification

1 reference

12 December 2020

Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods

1 reference

12 December 2020

Examination of specific DNA by PCR in patients with different forms of Lyme borreliosis

1 reference

12 December 2020

The amber theory of Lyme arthritis: initial description and clinical implications

1 reference

12 December 2020

Persistence of Borrelia garinii and Borrelia afzelii in patients with Lyme arthritis

1 reference

12 December 2020

Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions

1 reference

12 December 2020

10.1007/S12223-013-0272-4

Identifiers

DOI

1 reference

19 October 2017

1 reference